Log in or Sign up for Free to view tailored content for your specialty!
Neurology News
Emory researchers developing visual tool to view effects of Alzheimer's, ASD on brain
Researchers at Emory University are developing a visual tool to view how conditions such as Alzheimer's disease and autism spectrum disorder affect the brain in real-time, the university announced in a press release.
DCVax-L improves OS in newly diagnosed or recurrent glioblastoma
The addition of an autologous tumor lysate-loaded dendritic vaccine to standard care extended OS among certain patients with glioblastoma, according to results of a prospective phase 3 trial published in JAMA Oncology.
Log in or Sign up for Free to view tailored content for your specialty!
Tool developed to predict dementia risk
A practical risk score tool has been developed to help people identify their potential risk for dementia, researchers reported in JAMA Network Open.
FDA requests additional information, extends goal date for application of MS treatment
The FDA has extended the Prescription Drug User Fee Act goal date to Dec. 28, for TG Therapeutics’ biologics license application of ublituximab for patients with relapsing forms of MS.
Continuous subcutaneous foslevodopa-foscarbidopa improves motor symptoms in advanced PD
Continuous subcutaneous foslevodopa-foscarbidopa improved motor symptoms and reduced motor fluctuations compared with oral levodopa-carbidopa in patients with advanced Parkinson’s disease, according to a study in The Lancet Neurology.
Kriya acquires Redpin Therapeutics, adds gene therapies for epilepsy, trigeminal neuralgia
Kriya Therapeutics Inc. announced the acquisition of biotech company Redpin Therapeutics Inc., bolstering Kriya’s neurology therapeutic portfolio by adding gene therapy programs for epilepsy and trigeminal neuralgia.
Digital brain health platform offers rapid, accurate assessment of dementia risk
A team of researchers at the University of Miami Miller School of Medicine have developed an online platform of metrics designed to assess a patient’s risk for developing Alzheimer’s disease and other neurological issues.
Healio Minute Podcast, Neurology Edition: Top Headlines - Week of November 14, 2022
In this edition, neurologic effects of COVID-19 among pediatric populations, FDA accepts NDA for extended-release carbidopa/levodopa, antihistamines could be promising therapy for Parkinson’s disease and more.
Pershing Square Foundation announces prize to fund cognitive health research
The Pershing Square Foundation announced the launch of the Maximizing Innovation in Neuroscience Discover prize to establish a community of multidisciplinary investigators who can improve understanding of the brain and cognition.
BrainCheck receives $1.5M grant to study digital cognitive care platform
BrainCheck Inc. has received a $1.5 million grant award from the Small Business Innovation Research program, which it will use to fund a study of CARE, its digital cognitive care management platform, the company announced in a news release.
-
Headline News
CDC warns of potential overdose risk from online pharmacy prescriptions
October 03, 20242 min read -
Headline News
AAP advocates against school suspensions, expulsions
October 03, 20243 min read -
Headline News
Study: No clear association between pet ownership and brain, heart health
October 03, 20241 min read
-
Headline News
CDC warns of potential overdose risk from online pharmacy prescriptions
October 03, 20242 min read -
Headline News
AAP advocates against school suspensions, expulsions
October 03, 20243 min read -
Headline News
Study: No clear association between pet ownership and brain, heart health
October 03, 20241 min read